Spero Therapeutics (SPRO – Research Report) received a Hold rating and price target from TD Cowen analyst Ritu Baral yesterday. The ...

John Kernan, TD Cowen managing director and retail analyst, joins 'Money Movers' to discuss how important Chinese exposure is ...

TD Cowen projected a positive outlook for Life Science Tools and Diagnostics stocks on Friday despite the sector's ...

TD Cowen analyst Brian Morrison downgraded Linamar Corp. to hold from buy, in part because “tariff uncertainty is bound to ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Blueprint Medicines (BPMC – Research Report). The ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company ...